New technologies and applications in infant B cell immunology

•New immune monitoring technologies enable sample-sparing analysis of infant specimens.•Differences between infant and adult immune responses remain underexplored.•Infant neutralizing antibodies can be potent without high somatic mutation levels. The human immune system changes dramatically with age...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current opinion in immunology 2019-04, Vol.57, p.53-57
Hauptverfasser: Nielsen, Sandra Cathrine Abel, Boyd, Scott Dexter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 57
container_issue
container_start_page 53
container_title Current opinion in immunology
container_volume 57
creator Nielsen, Sandra Cathrine Abel
Boyd, Scott Dexter
description •New immune monitoring technologies enable sample-sparing analysis of infant specimens.•Differences between infant and adult immune responses remain underexplored.•Infant neutralizing antibodies can be potent without high somatic mutation levels. The human immune system changes dramatically with age, and early life exposures to pathogens and environmental antigens begin the formation of immune memory which influences subsequent responses later in life. To study infant immunity, sample-sparing experimental methods that extract maximal data from small samples of blood or other tissues are needed; fortunately, recent developments in high-throughput sequencing and multiplexed labeling and measurement of markers on cells are well-suited to these tasks. Here, we review some recent studies of infant immune responses to infectious disease, highlighting similarities and differences between infants and adults, and identifying important questions for future research. Recent clinical trials in food allergy have revealed the critical role of immunological events in the first year of life that determine an individual’s risk of developing peanut allergy; these also warrant thorough evaluation using the new immune monitoring tools.
doi_str_mv 10.1016/j.coi.2018.12.005
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6511472</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0952791518301523</els_id><sourcerecordid>2187532017</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-a16cfb92e7504764dc1d7d5fd2fff22ace74fff2a539e28077762e914d4bd043</originalsourceid><addsrcrecordid>eNp1kF1LwzAUhoMoOqc_wBvppTetSdo0LaKgwy8YerP7kCWnW0abzKad7N-buTn0QgicQJ7znpwHoQuCE4JJfr1IlDMJxaRICE0wZgdoQApexjjl9BANcMlozEvCTtCp9wscCJbiY3SS4oKynBcDdPsGn1EHam5d7WYGfCStjuRyWRslO-Osj4wNp5K2ix4iBXUdmabpv_H1GTqqZO3hfFeHaPL0OBm9xOP359fR_ThWGSNdLEmuqmlJgTOc8TzTimiuWaVpVVWUSgU829wkS0ugBeac5xRKkulsqnGWDtHdNnbZTxvQCmzXylosW9PIdi2cNOLvizVzMXMrkTNCMk5DwNUuoHUfPfhONMZvdpEWXO8FDdZYGkTygJItqlrnfQvVfgzBYmNdLESwLjbWBaEiOA09l7__t-_40RyAmy0AQdLKQCu8MmAVaNOC6oQOgf_HfwFQVJPK</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2187532017</pqid></control><display><type>article</type><title>New technologies and applications in infant B cell immunology</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Nielsen, Sandra Cathrine Abel ; Boyd, Scott Dexter</creator><creatorcontrib>Nielsen, Sandra Cathrine Abel ; Boyd, Scott Dexter</creatorcontrib><description>•New immune monitoring technologies enable sample-sparing analysis of infant specimens.•Differences between infant and adult immune responses remain underexplored.•Infant neutralizing antibodies can be potent without high somatic mutation levels. The human immune system changes dramatically with age, and early life exposures to pathogens and environmental antigens begin the formation of immune memory which influences subsequent responses later in life. To study infant immunity, sample-sparing experimental methods that extract maximal data from small samples of blood or other tissues are needed; fortunately, recent developments in high-throughput sequencing and multiplexed labeling and measurement of markers on cells are well-suited to these tasks. Here, we review some recent studies of infant immune responses to infectious disease, highlighting similarities and differences between infants and adults, and identifying important questions for future research. Recent clinical trials in food allergy have revealed the critical role of immunological events in the first year of life that determine an individual’s risk of developing peanut allergy; these also warrant thorough evaluation using the new immune monitoring tools.</description><identifier>ISSN: 0952-7915</identifier><identifier>EISSN: 1879-0372</identifier><identifier>DOI: 10.1016/j.coi.2018.12.005</identifier><identifier>PMID: 30825678</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; B-Lymphocytes - immunology ; Clinical Trials as Topic ; Communicable Diseases - immunology ; Food Hypersensitivity - immunology ; High-Throughput Nucleotide Sequencing ; Humans ; Infant ; Infant, Newborn ; Inventions ; Monitoring, Immunologic - methods</subject><ispartof>Current opinion in immunology, 2019-04, Vol.57, p.53-57</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-a16cfb92e7504764dc1d7d5fd2fff22ace74fff2a539e28077762e914d4bd043</citedby><cites>FETCH-LOGICAL-c451t-a16cfb92e7504764dc1d7d5fd2fff22ace74fff2a539e28077762e914d4bd043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.coi.2018.12.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30825678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nielsen, Sandra Cathrine Abel</creatorcontrib><creatorcontrib>Boyd, Scott Dexter</creatorcontrib><title>New technologies and applications in infant B cell immunology</title><title>Current opinion in immunology</title><addtitle>Curr Opin Immunol</addtitle><description>•New immune monitoring technologies enable sample-sparing analysis of infant specimens.•Differences between infant and adult immune responses remain underexplored.•Infant neutralizing antibodies can be potent without high somatic mutation levels. The human immune system changes dramatically with age, and early life exposures to pathogens and environmental antigens begin the formation of immune memory which influences subsequent responses later in life. To study infant immunity, sample-sparing experimental methods that extract maximal data from small samples of blood or other tissues are needed; fortunately, recent developments in high-throughput sequencing and multiplexed labeling and measurement of markers on cells are well-suited to these tasks. Here, we review some recent studies of infant immune responses to infectious disease, highlighting similarities and differences between infants and adults, and identifying important questions for future research. Recent clinical trials in food allergy have revealed the critical role of immunological events in the first year of life that determine an individual’s risk of developing peanut allergy; these also warrant thorough evaluation using the new immune monitoring tools.</description><subject>Adult</subject><subject>B-Lymphocytes - immunology</subject><subject>Clinical Trials as Topic</subject><subject>Communicable Diseases - immunology</subject><subject>Food Hypersensitivity - immunology</subject><subject>High-Throughput Nucleotide Sequencing</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Inventions</subject><subject>Monitoring, Immunologic - methods</subject><issn>0952-7915</issn><issn>1879-0372</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kF1LwzAUhoMoOqc_wBvppTetSdo0LaKgwy8YerP7kCWnW0abzKad7N-buTn0QgicQJ7znpwHoQuCE4JJfr1IlDMJxaRICE0wZgdoQApexjjl9BANcMlozEvCTtCp9wscCJbiY3SS4oKynBcDdPsGn1EHam5d7WYGfCStjuRyWRslO-Osj4wNp5K2ix4iBXUdmabpv_H1GTqqZO3hfFeHaPL0OBm9xOP359fR_ThWGSNdLEmuqmlJgTOc8TzTimiuWaVpVVWUSgU829wkS0ugBeac5xRKkulsqnGWDtHdNnbZTxvQCmzXylosW9PIdi2cNOLvizVzMXMrkTNCMk5DwNUuoHUfPfhONMZvdpEWXO8FDdZYGkTygJItqlrnfQvVfgzBYmNdLESwLjbWBaEiOA09l7__t-_40RyAmy0AQdLKQCu8MmAVaNOC6oQOgf_HfwFQVJPK</recordid><startdate>20190401</startdate><enddate>20190401</enddate><creator>Nielsen, Sandra Cathrine Abel</creator><creator>Boyd, Scott Dexter</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190401</creationdate><title>New technologies and applications in infant B cell immunology</title><author>Nielsen, Sandra Cathrine Abel ; Boyd, Scott Dexter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-a16cfb92e7504764dc1d7d5fd2fff22ace74fff2a539e28077762e914d4bd043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>B-Lymphocytes - immunology</topic><topic>Clinical Trials as Topic</topic><topic>Communicable Diseases - immunology</topic><topic>Food Hypersensitivity - immunology</topic><topic>High-Throughput Nucleotide Sequencing</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Inventions</topic><topic>Monitoring, Immunologic - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nielsen, Sandra Cathrine Abel</creatorcontrib><creatorcontrib>Boyd, Scott Dexter</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current opinion in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nielsen, Sandra Cathrine Abel</au><au>Boyd, Scott Dexter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New technologies and applications in infant B cell immunology</atitle><jtitle>Current opinion in immunology</jtitle><addtitle>Curr Opin Immunol</addtitle><date>2019-04-01</date><risdate>2019</risdate><volume>57</volume><spage>53</spage><epage>57</epage><pages>53-57</pages><issn>0952-7915</issn><eissn>1879-0372</eissn><abstract>•New immune monitoring technologies enable sample-sparing analysis of infant specimens.•Differences between infant and adult immune responses remain underexplored.•Infant neutralizing antibodies can be potent without high somatic mutation levels. The human immune system changes dramatically with age, and early life exposures to pathogens and environmental antigens begin the formation of immune memory which influences subsequent responses later in life. To study infant immunity, sample-sparing experimental methods that extract maximal data from small samples of blood or other tissues are needed; fortunately, recent developments in high-throughput sequencing and multiplexed labeling and measurement of markers on cells are well-suited to these tasks. Here, we review some recent studies of infant immune responses to infectious disease, highlighting similarities and differences between infants and adults, and identifying important questions for future research. Recent clinical trials in food allergy have revealed the critical role of immunological events in the first year of life that determine an individual’s risk of developing peanut allergy; these also warrant thorough evaluation using the new immune monitoring tools.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30825678</pmid><doi>10.1016/j.coi.2018.12.005</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0952-7915
ispartof Current opinion in immunology, 2019-04, Vol.57, p.53-57
issn 0952-7915
1879-0372
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6511472
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adult
B-Lymphocytes - immunology
Clinical Trials as Topic
Communicable Diseases - immunology
Food Hypersensitivity - immunology
High-Throughput Nucleotide Sequencing
Humans
Infant
Infant, Newborn
Inventions
Monitoring, Immunologic - methods
title New technologies and applications in infant B cell immunology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T08%3A21%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20technologies%20and%20applications%20in%20infant%20B%20cell%20immunology&rft.jtitle=Current%20opinion%20in%20immunology&rft.au=Nielsen,%20Sandra%20Cathrine%20Abel&rft.date=2019-04-01&rft.volume=57&rft.spage=53&rft.epage=57&rft.pages=53-57&rft.issn=0952-7915&rft.eissn=1879-0372&rft_id=info:doi/10.1016/j.coi.2018.12.005&rft_dat=%3Cproquest_pubme%3E2187532017%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2187532017&rft_id=info:pmid/30825678&rft_els_id=S0952791518301523&rfr_iscdi=true